Is there any Benefit for the Brain Metastasis with Cystic Components Rather than Sold Component only in Non-Small Cell Lung Cancer in terms of Clinical Outcome? |Biomedgrid
Journal: American Journal of Biomedical Science & Research (Vol.7, No. 6)Publication Date: 2020-03-03
Authors : Koun Jeong; Geun Young Yang; Young Zoon Kim;
Page : 487-494
Keywords : Brain metastases; Cyst; Tyrosine kinase inhibitor; Chemotherapy; Radiotherapy; Lung cancer Introduction;
Abstract
Background: Brain metastases (BM) is an important factor in shortening the lives of patients with lung cancer. It is not rare that the physician encounters the brain metastases with cystic components. We analyzed the efficacy and prognosis of different therapeutic schedules in BM of NSCLC patients with cystic component.
Other Latest Articles
- Is Cholesterol the Key Factor for Autism? |Biomedgrid
- H2Oslim®, the water-soluble polysaccharides from Agaricus bisporus, significantly reduces body weight and improves lipid parameters in overweight humans in a randomized double-blind vs placebo study |Biomedgrid
- Measures on Reducing the Recurrence of Colorectal Polyps |Biomedgrid
- Contrasting Organizational Transformations in NonHealth and Healthcare - Implications for Digital Health |Biomedgrid
- Isthmocele - To Treat or Not to Treat? |Biomedgrid
Last modified: 2023-05-30 21:53:09